The interdisciplinary team at John Muir Health Cancer Institute recognizes that the treatment of cancer requires a unique approach for each person. Our physicians are regionally recognized and nationally renowned for their work in delivering the most effective treatments for cancer.
The John Muir Health Cancer program is an American College of Surgeons (ACoS) / Commission on Cancer (CoC) accredited Integrated Network Cancer Program (INCP) (1 of 2 facilities in California/Scripps) with 2,504 new cancer cases in 2015. It has been recognized as a Nationally Accredited Program for Breast Centers (NAPBC) since 2010.
BREAST CANCER
Charleen Kim, MD, discusses the most common type of cancer in women, breast cancer.
CANCER GENETICS
Margo Thelander, MS, also discusses the primary care providers role as the gate keeper, for patient risk assessment and prevention of disease.
CLINICAL MINUTES: ROBOTIC PARTIAL NEPHRECTOMY
Brian Hopkins, MD, looks at the new technology, Robotic Partial Nephrectomy, in the treatment of kidney cancer.
CLINICAL MINUTES: MICROSURGICAL AND RADIOSURGICAL TREATMENT OF METASTATIC TUMORS
George J. Counelis, MD, Medical Director of the Brain Tumor & Neuro-Oncology Program, discusses the technology available within the department's Radiosurgery program - allowing precise treatment for cancer patients.
CLINICAL MINUTES: LUNG CANCER SCREENING
Michaela Straznicka, MD, discusses Lung Cancer Screening as implemented by US the Preventive Services Task Force - including insurance coverage and treatment options dependent on outcome.
CLINICAL MINUTES: TREATING OVARIAN CANCER PATIENTS WITH PARP INHIBITORS
Babak Edraki, MD, Gynecologic Oncologist with John Muir Health explains the latest protocol for ovarian patient treatment.
